Home > Journals > Minerva Obstetrics and Gynecology > Past Issues > Minerva Obstetrics and Gynecology 2021 October;73(5) > Minerva Obstetrics and Gynecology 2021 October;73(5):572-87

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

REVIEW  ENDOMETRIOSIS AND PELVIC PAIN 

Minerva Obstetrics and Gynecology 2021 October;73(5):572-87

DOI: 10.23736/S2724-606X.21.04776-X

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

Medical management of endometriosis

Alexis L. NEWMARK , Danielle E. LUCIANO, Amanda ULRICH, Anthony A. LUCIANO

Department of Obstetrics and Gynecology, University of Connecticut, Farmington, CT, USA



Endometriosis is a benign gynecologic disorder that is defined as functional endometrial tissue outside of the uterine cavity. It is an estrogen-dependent, inflammatory disease that leads to symptoms of pelvic pain, dysmenorrhea, dyspareunia, and infertility, occurring in 6-10% of reproductive aged women. The severity of the disease ranges from asymptomatic to debilitating symptoms that have a major impact on women’s lives. It is a chronic, recurrent disease, frequently requiring long term management until menopause and beyond. It is considered a chronic disorder that is managed with surgery, medical treatment, and oftentimes, both. Current medical therapy for endometriosis is considered suppressive of the disease, rather than curative. Fortunately, many patients do experience improvement and control of their symptoms with medical therapy. However, long-term efficacy of the medical treatments is often limited by side effects and the cost of therapy, and symptoms do tend to recur after discontinuation of these medications. This review summarizes our understanding of the pathogenesis of endometriosis and provides more in-depth discussion of specific medical management options used to treat endometriosis, including mechanism of action and side effects. It also provides recommendations on strategy with a forward look to novel endometriosis treatments in the future. The authors emphasized that endometriosis is a chronic disorder requiring long term medical therapy. Early diagnosis of endometriosis is key in preventing severe, debilitating symptoms and progression of disease. By utilizing our current knowledge of the pathophysiology of endometriosis and by correctly implementing currently available medical and surgical therapies we can significantly reduce the physical, psychosocial and financial burden of this chronic, recurrent and indolent disease. Current available medications are suppressive therapies, but the authors are looking forward to future therapies that can effectively cure or at least control endometriosis with minimal side effects. Future research should continue to look for the genetic trigger for endometriosis which can lead us to its underlying pathogenesis and eventually a cure or prevention.


KEY WORDS: Androgens; Aromatase inhibitors; Central nervous system sensitization; Contraceptive agents, hormonal; Endometriosis

top of page